HomeOCUL • NASDAQ
add
Ocular Therapeutix Inc
Previous close
$9.06
Day range
$8.83 - $9.34
Year range
$5.79 - $16.44
Market cap
1.93B USD
Avg Volume
5.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 13.25M | -22.43% |
Operating expense | 30.62M | 17.58% |
Net income | -64.65M | -33.62% |
Net profit margin | -487.95 | -72.26% |
Earnings per share | -0.29 | 0.00% |
EBITDA | -68.51M | -36.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 737.06M | 87.98% |
Total assets | 808.06M | 76.46% |
Total liabilities | 153.75M | 7.82% |
Total equity | 654.31M | — |
Shares outstanding | 217.69M | — |
Price to book | 2.99 | — |
Return on assets | -28.61% | — |
Return on capital | -32.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -64.65M | -33.62% |
Cash from operations | -54.25M | -37.59% |
Cash from investing | -2.84M | -1,305.45% |
Cash from financing | 449.38M | 9,857.37% |
Net change in cash | 392.29M | 1,217.06% |
Free cash flow | -37.01M | -52.32% |
About
CEO
Founded
2006
Headquarters
Website
Employees
325
